The Bubble Bursts

When Chris started a phase-three clinical trial for a promising ALS drug, the Snows were hopeful. As the months wore on and Chris' disease didn't seem to be progressing at all, they were thrilled. Each month with no change to Chris' health made the notion that this experimental medicine could stop his ALS in its tracks seem like a real possibility. And then, in April 2020, nine months after Chris joined the trial, that possibility crumbled with one photograph. Looking at that picture, K...